All News

    First Patient Dosed With Recombinant Bacillus Calmette-Guérin in Bladder Cancer

    March 13th 2025, 3:00pm

    Article

    Following the Bacillus Calmette-Guérin shortage, the first patient with bladder cancer has been dosed with recombinant Bacillus Calmette-Guérin in the U.S.

    Xtandi and Talzenna Therapy Shows Responses in Advanced Prostate Cancer

    March 13th 2025, 1:00pm

    Video

    Dr. Chandler Park sat down for an interview with CURE® to discuss the biggest takeaway from the 2025 ASCO GU Symposium in terms of prostate cancer therapy.

    Tedopi Cancer Vaccine Meets Trial End Point For Pancreatic Cancer

    March 12th 2025, 9:00pm

    Article

    The phase 2 TEDOPaM trial evaluating patients with advanced or metastatic pancreatic ductal adenocarcinoma met its primary end point.

    Bringing Together the CAR T-Cell Therapy Community

    March 12th 2025, 7:26pm

    Article

    It’s easy to think of scientific researchers as existing in a vacuum.

    Nutrition is Key Following a Cancer Diagnosis

    March 12th 2025, 7:14pm

    Article

    Nutrition is a challenge for many patients with cancer.

    The Leukemia & Lymphoma Society is Helping Patients With Medial Debt

    March 12th 2025, 7:01pm

    Article

    Cancer is one of the most expensive medical conditions to treat in the U.S.

    Discussing the Mission of CURE With Our Former and New Editors-In-Chief

    March 12th 2025, 7:00pm

    Video

    Our longtime editor-in-chief offers advice to his successor while discussing the news and education CURE magazine provides for patients with cancer, families and caregivers.

    Four Things to Remember When Both Spouses Have Cancer

    March 12th 2025, 5:00pm

    Article

    When my spouse and I both faced cancer, maintaining a positive attitude, seeking support, listening empathetically and managing stress helped us through it.

    First Patients Enrolled in Trial on Anti-HER2 Therapy in HER2+ Breast Cancer

    March 12th 2025, 4:00pm

    Article

    The first patients have been enrolled in the HEROES trial, exploring de-escalation of anti-HER2 therapy in metastatic HER2+ breast cancer using circulating tumor DNA.

    Targeted Axillary Dissection Offers a Precise Option in Breast Cancer

    March 12th 2025, 3:00pm

    Video

    Dr. Kandace P. McGuire discusses how targeted axillary staging differs from traditional methods of staging in patients undergoing breast cancer treatment.